Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close
Healthcare & PharmaceuticalFinancing

NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

November 11, 2025 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced that it has entered into a securities purchase agreement with a single healthcare institutional investor for the purchase and sale of 3,571,429 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.68 per share in a registered direct offering (the "Offering"). The gross proceeds from the Offering are expected to be approximately $6...

Read more
VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge
Healthcare & PharmaceuticalCompany Update

VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge

November 11, 2025 8:21 AM

VSee Health, Inc. (Nasdaq:VSEE) a leader in HIPAA-compliant telemedicine solutions, leveraging its newly secured FedRAMP Moderate authorization to deliver secure, scalable telehealth services to federal agencies and beyond. In a bold step forward, VSee is integrating advanced robotic assistance into intensive care units (ICUs), enabling remote clinicians to monitor and intervene in real-time - potentially transforming critical care delivery....

Read more
Who is the Best MTF Top Surgeon?
Healthcare & PharmaceuticalAdvertorial

Who is the Best MTF Top Surgeon?

November 11, 2025 8:00 AM

In the conversations around male-to-female (MTF) transgender top surgery (breast augmentation), one name has risen to the top: Dr. Javad Sajan of Allure Esthetic in Seattle. Dr. Sajan is widely regarded as the best MTF top surgeon, known for pioneering a scarless approach to breast augmentation that is transforming outcomes for transgender women. By performing MTF breast augmentation through hidden incisions, he virtually eliminates chest scars,...

Read more
Tenon Medical(R) Announces Pricing of At-The-Market PIPE Financing
Healthcare & PharmaceuticalFinancing

Tenon Medical(R) Announces Pricing of At-The-Market PIPE Financing

November 11, 2025 8:00 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced the pricing of an at-the-market private investment in public equity (the "PIPE") financing with several accredited investors for total gross proceeds of $2,850,000. The PIPE is designed to provide accretive capital through participation from strategic industry partners and members...

Read more
Clip on Veneers - Instasmile 2025's Affordable Smile Make Over
Healthcare & PharmaceuticalAdvertorial

Clip on Veneers - Instasmile 2025's Affordable Smile Make Over

November 11, 2025 7:16 AM

As Americans face record-high dental care costs - with 46% skipping or delaying treatment due to price pressures (ADA Health Policy Institute, USA Today, 2025) - affordable cosmetic dentistry is more relevant than ever. Yet the global cosmetic dentistry market continues to expand, projected to grow 13.5% annually through 2030, reaching $89 billion worldwide (Grand View Research, 2023). Amid this paradox of inflation and demand, instasmile, the...

Read more
Senzime to Present at Redeye and BioStock Investor Conferences
Healthcare & PharmaceuticalCompany Update

Senzime to Present at Redeye and BioStock Investor Conferences

November 11, 2025 7:15 AM

Senzime (STO:SEZI)(OTCQX:SNZZF), a leader in solutions for personalized anesthesia, today announced that Philip Siberg, CEO of Senzime, will be presenting at the following investor conferences this week. Redeye Medtech & Diagnostics Theme Event Date: Nov 12, 2025 Time: 11:45 CET Event Page: https://www.redeye.se/events/1110236/redeye-theme-medtech-diagnostics-4 Biostock Summit Date: Nov 13, 2025 Time: 14:40 CET Event Page:...

Read more
Zomedica Announces
Healthcare & PharmaceuticalCompany Update

Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review

November 11, 2025 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, today announced a special session of its "Fourth Friday at Four" investor webinar series. To accommodate the holiday calendar, this month's webinar will be held on the third Friday-November 21, 2025 at 4:00 p.m. Eastern Time. The November program will provide a comprehensive...

Read more
SoftWriters Launches Alpha Labs Team to Advance AI and Automation Innovation
Healthcare & PharmaceuticalCompany Update

SoftWriters Launches Alpha Labs Team to Advance AI and Automation Innovation

November 11, 2025 6:00 AM

SoftWriters, the leading provider of pharmacy management solutions for long-term care pharmacies, today announced the creation of Alpha Labs, a new cross-functional innovation team dedicated to accelerating the company's artificial intelligence (AI) and automation strategy. The Alpha Labs team will focus on identifying the optimal pathways to unlock AI and automation across SoftWriters' product suite. With a clear roadmap and validated product...

Read more
Mentavi Health Introduces
Healthcare & PharmaceuticalProduct Announcements

Mentavi Health Introduces "Mentavi Concierge" - Setting a New Standard for Responsible AI in Digital Health

November 11, 2025 6:00 AM

Mentavi Health, a leader in evidence-based digital mental health care, has launched Mentavi Concierge, its next-generation AI support assistant that enhances the digital health journey of visitors and patients while keeping human clinicians at the center of care. Mentavi Concierge represents the company's belief in the ethical use of AI: as a powerful tool for access, efficiency, and personalization - but never as a replacement for human...

Read more
AlzeCure Publishes its Interim Report for January - September 2025
Healthcare & PharmaceuticalEarnings

AlzeCure Publishes its Interim Report for January - September 2025

November 11, 2025 2:15 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - September 2025 is now available on the company's website: www.alzecurepharma.com/en/section/investors/financial-reports/ "The third quarter of 2025 was an active and eventful quarter for AlzeCure Pharma. In July, we received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA)...

Read more
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025
Healthcare & PharmaceuticalEarnings

CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

November 10, 2025 6:15 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the third quarter ended September 30, 2025, after the stock market closes on Thursday, November 13, 2025. The Company will hold a conference call with the investment...

Read more
FACT's New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients
Healthcare & PharmaceuticalProduct Announcements

FACT's New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients

November 10, 2025 6:10 PM

The Foundation for the Accreditation of Cellular Therapy (FACT) today published the Standards for Immune Effector Cells in the Community Clinical Setting, 1st edition, to help community oncology programs deliver transformative cell therapies closer to where eligible patients live and work. "These Standards, and FACT's accompanying voluntary accreditation, will help assure community-based caregivers, patients, and all stakeholders that the...

Read more
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ
Healthcare & PharmaceuticalCompany Update

CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ

November 10, 2025 4:05 PM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today announced that it has received a letter dated November 5, 2025, with a delisting determination from Nasdaq Stock Market LLC (the "Determination"). As previously reported, on May 5, 2025, Nasdaq...

Read more
The National Children's Cancer Society (NCCS) Announces New Mission and Vision Statements Reflecting Its Continued Commitment to Families Impacted by Childhood Cancer
Healthcare & PharmaceuticalCompany Update

The National Children's Cancer Society (NCCS) Announces New Mission and Vision Statements Reflecting Its Continued Commitment to Families Impacted by Childhood Cancer

November 10, 2025 4:00 PM

The National Children's Cancer Society (NCCS), a leading nonprofit dedicated to supporting children with cancer, their families, and survivors, has announced a new mission statement that reflects the organization's expanded and comprehensive approach to care. For 38 years, the NCCS has stood beside families navigating the challenges of childhood cancer, offering support where it's needed most. Founded in 1987 by Mark and Carol Stolze and Mark's...

Read more
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025
Healthcare & PharmaceuticalEarnings

Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025

November 10, 2025 3:50 PM

Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2025. Revenue for the quarters ended September 30, 2025 was $12.7 million compared to $13.6 million for the quarter ended September 30, 2024, a decrease of $0.9 million or approximately 6.6%. The Company had operating income for the quarter ended September 30, 2025 and 2024 of approximately $0.2 million and $0.5...

Read more
Reporting Of Transactions Made By Persons Discharging Managerial Responsibilities And Persons Closely Associated With Them In Gubra A/S' Shares
Healthcare & PharmaceuticalRegulatory

Reporting Of Transactions Made By Persons Discharging Managerial Responsibilities And Persons Closely Associated With Them In Gubra A/S' Shares

November 10, 2025 3:45 PM

Gubra (CPH:GUBRA) Pursuant to the Market Abuse Regulation article 19, Gubra A/S, CVR no. 30514041 (the "Company") hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in the Company and persons closely associated with them in the Company's shares and other financial instruments linked thereto. 1. Details of the person discharging managerial responsibilities/person closely...

Read more
Federal Marijuana Crackdown Confirms the Future: DEA's Obstruction of MMJ Science Exposed as Congress Moves to Re-Criminalize the $30 Billion THC Gray Market
Healthcare & PharmaceuticalCompany Update

Federal Marijuana Crackdown Confirms the Future: DEA's Obstruction of MMJ Science Exposed as Congress Moves to Re-Criminalize the $30 Billion THC Gray Market

November 10, 2025 2:15 PM

The chaotic, multi-billion dollar cannabis gray market created by the 2018 Farm Bill will soon be officially over. Simultaneous actions by the federal government-Congressional legislation, a unified front of 39 State Attorneys General, and local law enforcement sweeps-confirm that only fully compliant pharmaceutical grade companies will define the future of cannabis in medicine. This regulatory convergence directly validates the decade long...

Read more
The National Children's Cancer Society Awards 50 Scholarships to Childhood Cancer Survivors Nationwide
Healthcare & PharmaceuticalCompany Update

The National Children's Cancer Society Awards 50 Scholarships to Childhood Cancer Survivors Nationwide

November 10, 2025 1:00 PM

The National Children's Cancer Society (NCCS) is proud to announce that 50 childhood cancer survivors have been awarded scholarships through the Beyond the Cure Ambassador Scholarship Program for the 2025-2026 academic year. To meet this year's class of recipients and read their inspiring essays, click here. This milestone reflects the NCCS's unwavering commitment to helping survivors pursue higher education. The Beyond the Cure Ambassador...

Read more
Desert Oasis Healthcare Expands Maternal Health Resources with New Maternal Health Educator Position and Updated Video Education Series
Healthcare & PharmaceuticalCompany Update

Desert Oasis Healthcare Expands Maternal Health Resources with New Maternal Health Educator Position and Updated Video Education Series

November 10, 2025 12:20 PM

Desert Oasis Healthcare (DOHC) is proud to announce a new addition to our highly-viewed online Maternal Education Video Series, designed to support expecting and new mothers with accessible, practical resources on pregnancy, childbirth, and early parenthood. Sandra Artinian, BSN, RN, DOHC's new Maternal Health Educator, recently joined the healthcare team with the goal of expanding maternal wellness support across the Coachella Valley and...

Read more
Brain Balance Expands to Brooklyn, New York, Led by Veteran Educator and Advocate Sarah Weeks
Healthcare & PharmaceuticalCompany Update

Brain Balance Expands to Brooklyn, New York, Led by Veteran Educator and Advocate Sarah Weeks

November 10, 2025 12:00 PM

Brain Balance, a leading brain health and development program that helps children, teens, and adults improve focus, behavior, and emotional well-being through an integrative, non-medical approach, is proud to announce the opening of its new center in Brooklyn, New York, led by Sarah Weeks, an educator, school leader, and longtime advocate for inclusive learning. Weeks brings over 20 years of experience in education, from classroom teaching and...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
A blue background with the word access on it
By Jennifer Hammers • June 14, 2026
Compare ACCESS Newswire vs Cision PR Newswire on pricing, features, reach, and reviews — and why companies are making the switch..
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?